United States 112th Congress Status: Died 1 D cosponsors

HRES 279 — Raising awareness of the risk of internal bleeding for patients taking anti-coagulant drugs.

Last action — Referred to the Subcommittee on Health.

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. Died in session

This bill died with 112th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications. Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.

Bill Text

We don't have the full text on file for this bill yet.

Read HRES 279 on the official United States source →

Action History

  1. Referred to the Subcommittee on Health.

  2. Referred to the House Committee on Energy and Commerce.

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HRES 279 do?
Declares that the House of Representatives seeks to raise public awareness of the risks associated with anticoagulant medications. Encourages pharmaceutical manufacturers and health care providers to properly communicate the risk of death associated with such drugs to their patients.
Who sponsors HRES 279?
HRES 279 is sponsored by Ben Chandler (Democrat).
What is the current status of HRES 279?
This bill died with 112th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HRES 279?
Track HRES 279 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HRES 279

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HRES 279

Last checked for changes about 15 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →